Cite
Oculomotor deficits in spinocerebellar ataxia type 3: Potential biomarkers of preclinical detection and disease progression.
MLA
Wu, Chao, et al. “Oculomotor Deficits in Spinocerebellar Ataxia Type 3: Potential Biomarkers of Preclinical Detection and Disease Progression.” CNS Neuroscience & Therapeutics, vol. 23, no. 4, Apr. 2017, pp. 321–28. EBSCOhost, https://doi.org/10.1111/cns.12676.
APA
Wu, C., Chen, D., Feng, L., Zhou, X., Zhang, J., You, H., Liang, X., Pei, Z., & Li, X. (2017). Oculomotor deficits in spinocerebellar ataxia type 3: Potential biomarkers of preclinical detection and disease progression. CNS Neuroscience & Therapeutics, 23(4), 321–328. https://doi.org/10.1111/cns.12676
Chicago
Wu, Chao, Ding‐Bang Chen, Li Feng, Xiang‐Xue Zhou, Ji‐Wei Zhang, Hua‐Jing You, Xiu‐Ling Liang, Zhong Pei, and Xun‐Hua Li. 2017. “Oculomotor Deficits in Spinocerebellar Ataxia Type 3: Potential Biomarkers of Preclinical Detection and Disease Progression.” CNS Neuroscience & Therapeutics 23 (4): 321–28. doi:10.1111/cns.12676.